AxoGen (NASDAQ:AXGN) Coverage Initiated by Analysts at Wells Fargo & Company
Wells Fargo & Company began coverage on shares of AxoGen (NASDAQ:AXGN – Free Report) in a research report report published on Thursday, MarketBeat.com reports. The firm issued an overweight rating and a $40.00 price target on the medical equipment provider’s stock. AXGN has been the topic of several other reports. HC Wainwright lifted their target [...]